Visikol uses Multiplex Imaging Tools with HMH
Visikol’s approach to multiplex imaging will provide important insights in the TB drug discovery process that are both timely and data driven.
Immuno-oncology Drug Discovery
The main goals of immuno-oncology therapeutics (immunotherapies) is to stimulate the immune system to be able to identify and selectively attack cancer cells, or mimic components of the immune system in the lab that can be used to restore/improve the immune system.
Recent Advances in Immuno-oncology
There has recently been a shift towards finding effective combinations of treatments such as pairing a checkpoint inhibitor with a costimulatory receptor to improve response rates.
High Content Screening For Immune Modulators
Cancer immunotherapies that target T cells via the blockage of immune checkpoints are a promising approach for cancer treatment.
Leica & Visikol: Multiplex Webinar
This webinar provides a background on various multiplex tissue imaging approaches and describes how they can be used to answer complex research questions.
Our Multiplex Immunolabel Approach
This blog post outlines Visikol’s approach to stripping and immunolabeling tissues for multiplex imaging.
Multiplex Slide Imaging Approaches
This overview outlines the two fundamental approaches for multiplex slide imaging: fluorescence and imaging mass cytometry (i.e. CyTOF).
Visikol’s Imaging Mass Cytometry Services
Check out our imaging mass cytometry services page for a full review of our IMC service offerings and capabilities.